ExoCoBio Funding: $47M Raised, Series C (2018)

ExoCoBio funding overview

ExoCoBio is based in Seoul, South Korea. ExoCoBio has raised $47M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series C announced in September 2018. The round record for ExoCoBio runs through 2018; nothing later has been disclosed. Investors on record include Seven Tree Equity Partners, CSQUARED Global Asset Management, TS Investment Partners, K2 Investment, Intervest, KDB Capital and 6 others. 12 distinct backers are named across the disclosed rounds.

ExoCoBio at a glance

Total raised: $47M
Latest round: Series C
Latest round date: September 2018
Headquarters: Seoul, South Korea
Notable investors: Seven Tree Equity Partners, CSQUARED Global Asset Management, TS Investment Partners, K2 Investment, Intervest, KDB Capital, Atinum Investment, GU Equity Partners

Frequently asked about ExoCoBio funding

How much has ExoCoBio raised?: ExoCoBio has raised $47M in total disclosed funding across the rounds on record.
Who has invested in ExoCoBio?: Seven Tree Equity Partners, CSQUARED Global Asset Management, TS Investment Partners, K2 Investment, Intervest, KDB Capital are named among the investors backing ExoCoBio.
What was the latest ExoCoBio funding round?: The most recent disclosed round is a Series C, announced in September 2018.
Where is ExoCoBio based?: ExoCoBio is based in Seoul, South Korea.
When did ExoCoBio last raise?: The last disclosed ExoCoBio round closed in September 2018 at Series C.

Every ExoCoBio figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Seoul at a similar stage.

ExoCoBio Funding: $47M Raised, Series C (2018)

ExoCoBio funding overview

ExoCoBio at a glance

Frequently asked about ExoCoBio funding

Companies related to ExoCoBio (19)

Browse related funding lists (6)